ClinicalTrials.gg
CompletedNCT07936331Wii ProtocolUpdated Nov 13, 2026

Aerobic Exergaming ( Wii ) Protocol : Influence on Reaction Time and Pulmonary Functions in Overweight Children

An interventional study of he Nintendo Wii Fit operates on the Wii system, produced by Nintendo Co., Ltd, based in Kyoto, Japan. and Chest physical therapy and diet therapy in Overweight and School Age Children, sponsored by Al-Zaytoonah University of Jordan. Completed at 1 site in Egypt. Open to participants aged 10 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Al-Zaytoonah University of Jordan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jul 2026, registered Nov 2026).
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
10 Years to 15 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 18 studies in Overweight with a site in Egypt — 4 open to participants now, 6 under way, none of them phase 3. Overweight · Egypt.

Enrollment
8th of 16
60 · median 60
Started
2026
with 2 others
No phase
12 of 18
2 open now
Registered
18th of 18
by date
Lead sponsor
1 of 18
Al-Zaytoonah University of Jordan

Among the 18 studies in Overweight with a site in Egypt, this one is the 8th largest by enrollment of the 16 interventional ones that give a count, is one of 3 that started in 2026, is one of 12 with no phase, and was the 18th registered.

Overweight

3,613 studies on the registry are indexed under Overweight; 861 are open to participants now.

Browse Overweight studies →

Open to participants now

4 of the 18 studies in Overweight with a site in Egypt are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 534 Overweight studies recruiting now, 159 (30%) set no upper age limit and 347 (65%) stop at 75 or younger; 64 take children under 18; 205 take healthy volunteers.

This study: 10 Years to 15 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Overweight with a site in Egypt, or all of them as a file.
02

Study summary

Structured Wii-based aerobic training is relevant because it combines whole-body exercise with interactive visual and auditory feedback. The proposed activities include stepping, running in place, Hula Hoop, and Rhythm Boxing, which require repeated limb and trunk movements, weight shifting, and coordination. The game format may help sustain interest in exercise, although improved adherence is a potential advantage rather than an established outcome of this study. The proposed 30-minute aerobic component, performed three times weekly for 12 weeks, provides a reproducible exercise exposure that can be supervised and adjusted to each child's tolerance (Elfahl and Elfeky, 2025).

Read the detailed description

Clinical evidence supports investigating active video games as an exercise adjunct in children with excess weight. Comeras-Chueca et al. (2022) studied 28 children aged 9-11 years with overweight or obesity in a five-month supervised program combining active video games with multicomponent exercise. The intervention improved cardiorespiratory responses at submaximal exercise intensities, but did not increase peak oxygen uptake. These findings support a potential benefit for exercise efficiency and tolerance while showing that benefits are outcome-specific and cannot be attributed to gaming alone.

The pulmonary rationale is supported by a pediatric randomized trial involving 76 children with inhalation injury following thermal burns. Elfahl and Elfeky (2025) reported favorable pulmonary-function, chest-expansion, six-minute-walk, and Timed Up and Go outcomes after 12 weeks of Wii aerobic training added to conventional chest treatment. This provides a relevant precedent for the intervention and outcome selection, but the underlying disease differs from childhood overweight. Consequently, a pulmonary benefit in overweight children remains a hypothesis requiring direct testing. Increased ventilatory demand and repeated trunk and upper-limb movements provide plausible physiological reasons to investigate respiratory outcomes; they do not establish the mechanism of any observed change.

The intervention also has a sensorimotor rationale. Wii games require participants to detect changing visual or auditory cues, coordinate movements, and initiate responses. Repeated practice may influence response speed, providing a reason to assess reaction time alongside physical outcomes. Nevertheless, executive-function findings cannot be treated as direct evidence of improved reaction time. Wu et al. (2023), in a meta-analysis of eight randomized trials involving 435 children and adolescents, found no statistically significant advantage of commercial exergames over conventional exercise for overall executive function and rated the evidence as very low quality. Reaction-time improvement will therefore be tested rather than presented as a proven benefit.

03

Conditions studied

  • Overweight
  • School Age Children

Browse trials for

Keywords

  • Wii protocol
  • Reaction time
  • Pulmonary Functions
04

Who can participate

Ages eligible
10 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. are boys or girls aged 10-15 years;
  2. meet the WHO -for-age criterion for overweight;
  3. are medically stable;
  4. are able to walk independently without an assistive device;
  5. are able to understand and follow verbal instructions;
  6. are able to participate safely in moderate-intensity physical activity; and
  7. Have written parental/legal guardian consent for participation.

Exclusion criteria

Exclusion Criteria:

  1. diagnosed respiratory disease that may independently influence pulmonary-function measurements;
  2. known cardiovascular disease contraindicating exercise;
  3. neurological disorders affecting movement, coordination, balance, or reaction time;
  4. significant musculoskeletal disorders or recent injury limiting walking, running, stepping, or upper-limb activity;
  5. visual or hearing impairment that prevents adequate interaction with the Wii system or reaction-time assessments;
  6. previous surgery or medical condition significantly affecting exercise performance;
  7. current participation in another structured exercise intervention or research trial likely to influence the study outcomes; or
  8. any medical condition for which the examining physician or investigator considers moderate aerobic exercise inappropriate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Chest physical therapy and diet therapy

    School age children who will receive routine chest physical therapy and diet therapy

    Other: Chest physical therapy and diet therapy

  • Experimental
    Chest physical therapy along with wii aerobic exercises and diet therapy

    School age children who will receive routine chest physical therapy along with wii aerobic exercises and diet therapy

    Device: he Nintendo Wii Fit operates on the Wii system, produced by Nintendo Co., Ltd, based in Kyoto, Japan. · Other: Chest physical therapy and diet therapy

Interventions

  • Devicehe Nintendo Wii Fit operates on the Wii system, produced by Nintendo Co., Ltd, based in Kyoto, Japan.

    The Nintendo Wii Fit operates on the Wii system, produced by Nintendo Co., Ltd, based in Kyoto, Japan. Among its features is a collection of interactive video games that require players to embody their on-screen character using a compact, wireless controller capable of motion detection.

  • OtherChest physical therapy and diet therapy

    Chest Physiotherapy: Breathing exercises (diaphragmatic breathing, segmental breathing) Incentive spirometry (if applicable) Thoracic expansion exercises Diet therapy : Individualized calorie-controlled diet plan

06

What researchers measure

Primary outcomes

  1. Forced vital capacity (FVC)

    The maximum amount of air expired after the maximum Inspiration in liters.

    Time frame: pre and post 36 sessions ( 3 sessions/week ) for 3 months

  2. Forced expiratory volume in 1 s (FEV1)

    The air volume expired in the first second after maximal Inspiration in liters.

    Time frame: pre and post 36 sessions ( 3 sessions/week ) for 3 months

  3. Peak expiratory flow (PEF)

    Achieving maximum forced expiration without hesitation from the point of peak lung inflation yields the maximum expiratory flow

    Time frame: pre and post 36 sessions ( 3 sessions/week ) for 3 months

Secondary outcomes

  1. Chest Expansion

    Upper chest expansion (2nd intercostal space) \& Lower chest expansion (xiphoid) were assessed from the reference point mentioned by using tab

    Time frame: Pre and post 36 sessions ( 3 sessions / week ) for 3 months

  2. 6-Minute Walk Test (6-MWT) ( To measure Functional Capacity )

    The children's submaximal functional capacity was evaluated by measuring the maximum distance they could walk in 6 min

    Time frame: Pre and post 36 sessions ( 3 sessions / week ) for 3 months

  3. Timed Up and Go test (TUG) ( To measure Functional Capacity )

    This straightforward evaluation of a child's mobility includes static and dynamic balancing measures .It considers how long it takes for an individual to stand up from a chair, walk 3 m, turn around, and then sit back down

    Time frame: Pre and post 36 sessions ( 3 sessions / week ) for 3 months

  4. Ruler Drop Test ( To measure reaction time )

    The Ruler Drop Test is a simple clinical method used to assess reaction time. A ruler is held vertically between the participant's thumb and index finger without contact. The examiner releases the ruler unexpectedly, and the participant attempts to catch it as quickly as possible

    Time frame: pre and post 36 sessions ( 3 sessions / week ) for 3 months

  5. Human Benchmark Reaction Time Test ( To measure reaction time )

    The Human Benchmark Reaction Time Test is a computerized assessment that measures visual reaction time. Participants are instructed to click (or tap) the screen as quickly as possible when a visual stimulus changes color (typically from red to green). The reaction time is automatically recorded in milliseconds.

    Time frame: pre and post 36 sessions ( 3 sessions / week ) for 3 months

07

Study locations

1 site
  • Outpatient Clinics of Universities and Private Medical Centers in Cairo, Cairo, Cairo 11571
    Cairo, Cairo Governorate 11571, Egypt
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Oct 2026, 3 months.

Of 1,308 non-industry interventional studies with no phase under Overweight, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 39. This study's 3 months is below that.

Counting every sponsor, half of 1,420 studies reached it within 17 months; a quarter within 8 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2026
First posted
Nov 13, 2026
StartActual
Jul 1, 2026
Primary completionActual
Oct 30, 2026
CompletionActual
Nov 5, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07936331
Lead sponsor
Al-Zaytoonah University of Jordan
Responsible party
Mohamed Saied Zidan (Doctor of Physical Therapy, Al-Zaytoonah University of Jordan) — Principal investigator
First posted
Nov 13, 2026
Start date
Jul 1, 2026
Primary completion
Oct 30, 2026
Completion
Nov 5, 2026
Last update
Nov 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion